Angel Matthew Insider Trades

Insider Trading History

Track insider trading activity for Angel Matthew. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tempest Therapeutics
Tempest Therapeutics TPST
10% owner, CEO And President
Holding Value $294k 231,482 shares
Last Trade
Mar 24, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$405k 231,482 shares
$1.75
$1.27
Tempest Therapeutics
Tempest Therapeutics TPST
10% owner, CEO And President
Holding Value $342k 269,621 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$642k 269,621 shares
$2.38
$1.27
Eterna Therapeutics
Eterna Therapeutics ERNA
Director, President And CEO
Holding Value $1.06M 132,003 shares
Last Trade
Jan 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.41M 132,003 shares
$71.25
$8.01
Eterna Therapeutics
Eterna Therapeutics ERNA
Director, Interim President And CEO
Holding Value $19.9M 2,487,003 shares
Last Trade
Aug 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$366M 2,487,003 shares
$147.00
$8.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up